Real-world evidence for more efficent, patient-focused trials
Parexel's Amy McKee and Leanne Larson make a case for an evidence-driven approach to drug development.
- Solutions Overview
-
Clinical Development
- Translational Medicine
- Early Phase
- Phase II-III
- Phase IIIb/IV
- Biostatistics
- Clinical Data Management
- Clinical Supply Chain Management
- Decentralized Clinical Trials
- Medical Monitoring & Consulting
- Medical Writing
- Patient Sensors
- Pharmacovigilance
- Risk-based Quality Management (RBQM)
- Expanded Access Services
- Outsourcing Services